HOME > SCIENCE > TESTING BY DEVICE TYPE > ORTHOPEDIC LOCATIONS | CONTACT US | SITEMAP
-
Testing by Device Type

Orthopedic

From a biocompatibility perspective, orthopedic devices can be examined as solid implant types made from polymers, ceramics and metals, and as pastes or two part systems that require mixing in situ before implant. Such devices are quite varied and can overlap with neurological devices when used in the vertebrae or as a skull replacement material. What these devices have in common is that all contact muscle and/or bone. Device materials that come in contact with nervous tissue, spinal fluid, dura mater or brain often require more comprehensive testing. (See Neurological Devices)

The following information applies primarily to hard implant devices (e.g. bone cement). NAMSA Technical Specialists and Scientists are adept at developing non-clinical programs for these products. Veterinary surgeons on staff are experienced at implanting and/or evaluating the biocompatibility and functionality of such devices.

While some orthopedic devices may be short term or "externally communicating," the majority are long-term implants. Depending upon the exact nature of the materials in the orthopedic device, testing concerns can be significant. This is a device category where one must also consider the carcinogenic (cancer causing) potential of the device materials.

Standards and Regulation

First consideration should be given to vertical standards (an FDA guideline or ISO standard in use for a specific device). In the absence of such guidance, ISO 10993 should be consulted to determine potential areas of concern for these devices.

Each device should be examined on it's own merits. In some cases, prior data may be available from suppliers or in the literature, or there may be efficacy or functionality testing in progress that may be used to satisfy a portion of the safety requirements.

Test Categories

The following test areas are considered for all solid orthopedic devices, regardless of the time the implant will be in the body:

Characterization of Materials

  • Thorough Chemical Characterization of all critical components

R & D Function and Performance

  • Anterior crutiate ligament repair
  • Ligament/tendon fixation
  • Fracture repairs
  • Long bone defect repair
  • Cortical, trabecular, cranial, maxillofacial defects
  • Osteoporosis
  • Osteoarthritis
  • Orthopedic prosthetic infection
  • Articular cartilage defects
  • Ligamentoplasty
  • Arthroplasty
  • Spinal fusion
  • Reconstruction of intervertebral disc
  • Disc replacement
  • Histopathology of device in situ

Biocompatibility

  • Cytotoxicity by the MEM Elution method
  • Sensitization or Allergenicity study
  • Intracutaneous injection or irritation screen
  • Acute Systemic toxicity screen
  • Implant test in muscle or subcutaneous tissue
  • Bone implant study commensurate with clinical use

Optional tests for longer term or lifetime implants

  • Subchronic and chronic systemic toxicity studies
  • Efficacy or functional orthopedic studies
  • Series of genotoxicity assays (generally 3)
  • Carcinogenicity evaluation

Note: two part epoxy systems or materials mixed at surgery or in situ may require a different testing approach (e.g. bone cement).

Complete Sterility Assurance Program

  • Sterilization validation
  • Environmental monitoring
  • Packaging validation and shelf life testing

This list provides an overview of testing programs for orthopedic devices. NAMSA Technical Specialists and Scientists will partner with you to develop a cost effective program and minimize your time to market. Our experts will help you design specific test programs based on the unique characteristics of each device.

NEED HELP?

Tell us what you need.

Or call us:

866.666.9455 (within the U.S.)
419.666.9455 (outside the U.S.)